XML 55 R32.htm IDEA: XBRL DOCUMENT v3.19.1
SEGMENT INFORMATION (Tables)
3 Months Ended
Mar. 31, 2019
Segment Reporting [Abstract]  
Information About Reportable Segments and Reconciliation of Segment Net Sales to Consolidated Net Sales and Segment Pre-Tax Income to Consolidated Pre-Tax Income
The table below presents information about Edwards Lifesciences' reportable segments (in millions):
 
Three Months Ended   
March 31,
 
2019
 
2018
Segment Net Sales
 

 
 

United States
$
562.8

 
$
479.5

Europe
227.3

 
205.3

Japan
99.2

 
91.1

Rest of World
96.8

 
91.7

Total segment net sales
$
986.1

 
$
867.6

Segment Operating Income
 

 
 

United States
$
383.3

 
$
313.8

Europe
119.4

 
103.0

Japan
61.0

 
54.8

Rest of World
30.8

 
29.0

Total segment operating income
$
594.5

 
$
500.6


The table below presents reconciliations of segment net sales to consolidated net sales and segment operating income to consolidated pre-tax income (in millions):
 
Three Months Ended   
March 31,
 
2019
 
2018
Net Sales Reconciliation
 

 
 

Segment net sales
$
986.1

 
$
867.6

Foreign currency
6.9

 
27.2

Consolidated net sales
$
993.0

 
$
894.8

Pre-tax Income Reconciliation
 

 
 

Segment operating income
$
594.5

 
$
500.6

Unallocated amounts:
 

 
 

Corporate items
(306.5
)
 
(248.1
)
Special charge (Note 5)
(24.0
)
 

Intellectual property litigation expenses
(4.6
)
 
(5.7
)
Foreign currency
14.8

 
5.7

Consolidated operating income
274.2

 
252.5

Non-operating income
3.8

 
11.0

Consolidated pre-tax income
$
278.0

 
$
263.5

Enterprise-Wide Information
Enterprise-wide information is based on actual foreign exchange rates used in the Company's consolidated condensed financial statements.
 
Three Months Ended   
March 31,
 
2019
 
2018
 
 
 
 
Net Sales by Geographic Area
 

 
 

United States
$
562.8

 
$
479.5

Europe
234.7

 
230.0

Japan
98.4

 
92.7

Rest of World
97.1

 
92.6

 
$
993.0

 
$
894.8

Net Sales by Major Product and Service Area
 

 
 

Transcatheter Aortic Valve Replacement
$
597.7

 
$
551.1

Transcatheter Mitral and Tricuspid Therapies
4.3

 
0.5

Surgical Structural Heart
214.7

 
179.5

Critical Care
176.3

 
163.7

 
$
993.0

 
$
894.8


 
March 31, 2019
 
December 31, 2018
 
(in millions)
Long-lived Tangible Assets by Geographic Area
 

 
 

United States
$
727.3

 
$
642.1

Europe
51.4

 
36.6

Japan
16.7

 
6.7

Rest of World
242.1

 
214.4

 
$
1,037.5

 
$
899.8